Treatment success rate for patients treated for MDR-TB in Equatorial Guinea

Equatorial Guinea: Treatment success rate for patients treated for MDR-TB was 54.0% in 2022. ▼ Falling

Latest (2022)
54.0%
Change on year
down 15.6%
World rank
136th
of 163 countries
All-time high
95.0%
in 2015
All-time low
33.0%
in 2014
Years of data
9
2014–2022

Treatment success rate for patients treated for MDR-TB in Equatorial Guinea, 2014–2022

4060801002014201820222014: 332015: 952016: 862017: 802018: 772019: 712020: 512021: 642022: 54

Source: World Health Organization, Global Health Observatory.

Analysis

Equatorial Guinea recorded 54.0% for treatment success rate for patients treated for mdr-tb in 2022.

That represents a change of down 15.6% on the previous year and up 63.6% over ten years.

Over the whole period, treatment success rate for patients treated for mdr-tb in Equatorial Guinea peaked at 95.0% in 2015 and was at its lowest, 33.0%, in 2014.

Equatorial Guinea ranks 136th of 163 countries on this measure, in the bottom quarter.

Treatment success rate for patients treated for MDR-TB in Equatorial Guinea, year by year

Annual values for Treatment success rate for patients treated for MDR-TB (%) in Equatorial Guinea, 2014 to 2022.
Year Value Change
2014 33.0%
2015 95.0% +187.9%
2016 86.0% -9.5%
2017 80.0% -7.0%
2018 77.0% -3.8%
2019 71.0% -7.8%
2020 51.0% -28.2%
2021 64.0% +25.5%
2022 54.0% -15.6%

Averages by decade

DecadeAverage LowestHighest Years
2010s 73.7% 33.0% 95.0% 6
2020s 56.3% 51.0% 64.0% 3

Countries ranked near Equatorial Guinea

  1. 133 Portugal 55.0% compare
  2. 133 Romania 55.0% compare
  3. 133 Colombia 55.0% compare
  4. 136 Türkiye 54.0% compare
  5. 136 Gabon 54.0% compare
  6. 139 Syrian Arab Republic 50.0% compare
  7. 139 Uruguay 50.0% compare
  8. 139 Lebanon 50.0% compare
  9. 139 Denmark 50.0%
  10. 139 Bulgaria 50.0% compare

See the full ranking of 175 places →

More health data for Equatorial Guinea

All data for Equatorial Guinea →

Frequently asked questions

What is treatment success rate for patients treated for mdr-tb in Equatorial Guinea?
Treatment success rate for patients treated for mdr-tb in Equatorial Guinea was 54.0% in 2022, according to World Health Organization, Global Health Observatory.
What is the highest treatment success rate for patients treated for mdr-tb recorded in Equatorial Guinea?
The highest recorded value was 95.0% in 2015.
What is the lowest treatment success rate for patients treated for mdr-tb recorded in Equatorial Guinea?
The lowest recorded value was 33.0% in 2014.
How does Equatorial Guinea rank for treatment success rate for patients treated for mdr-tb?
Equatorial Guinea ranks 136th out of 163 countries with data for 2022.
Is treatment success rate for patients treated for mdr-tb rising or falling in Equatorial Guinea?
Over the last ten years it is up 63.6%. The long-run trend across the full record is falling.
Where does this Equatorial Guinea data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 9 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Treatment success rate for patients treated for MDR-TB in Equatorial Guinea. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 September 2026, from https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/equatorial-guinea/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/equatorial-guinea/">Treatment success rate for patients treated for MDR-TB in Equatorial Guinea</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed